Tolerate Chemotherapy Better!
The treatment of cancer with chemotherapy aims to kill tumor cells - while sparing the healthy body cells as much as possible.
A large number of different medications are available today for this purpose.
It is important that the therapy dose and the number of chemotherapy cycles calculated by doctors can be tolerated and administered.
Since many of these treatments are also associated with chemotherapy-induced side effects in the digestive organs, supportive therapies - such as MED THERAPY-PRO (PMA zeolite) - are usually recommended by physicians.
In a clinical study, it could be proven that MED THERAPY-PRO increased the tolerance of chemotherapy.
- Men and women had fewer treatment discontinuations.
- Men and women had better blood counts.
- Men in particular, had fewer chemotherapy-induced peripheral neuropathies (a side effect often associated with tingling and numbness in the limbs).
71.7 % of patients were able to complete more chemotherapy cycles (>8) due to PMA zeolite treatment.
21 %fewer treatment discontinuations with MED THERAPY-PRO compared to the placebo; in the MED THERAPY-PRO group, there was a better adherence to the treatment schedule.
Panaceo MED THERAPY-PRO
Gold Standard Study confirms:
- Significantly improves the tolerability of chemotherapy
- Reduces treatment discontinuations
- Alleviates side effects
- Increases the success of therapy
- Strengthens intestine and liver